ProKidney Corp.
PROK
$2.27
$0.020.67%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/1/2025
-
Ticker Report
11/24/2025
-
Ticker Report
11/16/2025
-
MarketBeat
11/16/2025
-
MarketBeat
11/16/2025
-
Simply Wall St
11/15/2025
-
MarketBeat
11/14/2025
-
MarketBeat
11/14/2025
-
Ticker Report
11/14/2025
-
ETF Channel
11/13/2025
-
TipRanks Financial Blog
11/11/2025
-
MarketBeat
11/11/2025
-
Nasdaq News: Markets
11/10/2025
-
GuruFocus
11/10/2025
-
GuruFocus
11/10/2025
-
The Fly
11/10/2025
-
Globe Newswire
11/10/2025
-
MarketBeat
11/6/2025
-
GuruFocus
11/6/2025
-
The Fly
11/6/2025
-
GuruFocus
11/6/2025
-
Globe Newswire
11/5/2025
-
MarketBeat
11/4/2025
-
MarketBeat
10/29/2025
-
MarketBeat
10/29/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, November 10, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
336 999 7028
Address
2000 Frontis Plaza Blvd.
Winston-Salem, NC 27103
Winston-Salem, NC 27103
Country
Year Founded
Business Description
Sector
ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate...
more